Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Studies that included few (n < 3) subjects and patients with hepatocellular carcinoma were excluded. Results: Late evening snack decreased lipid oxidation and improved nitrogen balance ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.